Titan Biotech Ltd
₹1212.15
(6.53%)
Sat, 14 Feb 2026, 10:23 pm
Health Technology
Biotechnology
24.5KTitan Biotech Enterprise Value (EV)
| Particulars | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 13.90 | 11.92 | 15.97 | 13.28 | 8.75 | 6.04 | 8.16 | 13.89 | 15.35 | 16.40 | 19.16 | 10.56 | 4.99 | 5.05 | 9.99 | 6.55 | 17.56 | 16.18 |
| Price to book ratio | 1.34 | 0.99 | 1.48 | 1.42 | 0.79 | 0.55 | 0.79 | 1.11 | 1.26 | 1.56 | 2 | 1.16 | 0.90 | 2.23 | 2.51 | 1.48 | 3.27 | 2.27 |
| Price to sales ratio | 0.85 | 0.63 | 0.83 | 0.73 | 0.48 | 0.29 | 0.31 | 0.56 | 0.59 | 0.68 | 0.85 | 0.57 | 0.44 | 1.08 | 1.75 | 1.13 | 2.66 | 2.23 |
| Price to cash flow ratio | 0 | 5.51 | 14.07 | 7.19 | 8.66 | 7.03 | 0 | 0 | 7.11 | 0 | 0 | 11.71 | 9.32 | 8.73 | 10.23 | 7.96 | 21.85 | 18.03 |
| Enterprise value | 109.21M | 88.68M | 144.14M | 160.42M | 121.53M | 95.16M | 171.98M | 300.25M | 360.56M | 550.74M | 744.39M | 603.82M | 596.14M | 1.67B | 2.19B | 1.66B | 4.42B | 3.46B |
| Enterprise value to EBITDA ratio | 8.28 | 6.55 | 9.39 | 8.36 | 5.54 | 3.63 | 5.39 | 7.61 | 9.31 | 10.21 | 10.67 | 6.76 | 4.42 | 3.63 | 6.92 | 5.54 | 12.64 | 13.28 |
| Debt to equity ratio | 0.07 | 0.06 | 0.14 | 0.29 | 0.12 | 0.25 | 0.46 | 0.38 | 0.53 | 0.98 | 1.06 | 0.74 | 0.61 | 0.23 | 0.10 | 0.08 | 0.06 | 0.02 |
| Return on equity % | 0 | 8.69 | 9.53 | 11.03 | 10.66 | 9.29 | 10.01 | 9.11 | 8.42 | 9.79 | 10.74 | 12.23 | 19.80 | 56.20 | 27.98 | 23.82 | 20.42 | 15.01 |
Titan Biotech Ltd Enterprise Value
The Titan Biotech Ltd Enterprise Value is a key financial metric used by investors to evaluate Titan Biotech Ltd's valuation, profitability, and overall financial performance. Tracking the Titan Biotech Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Titan Biotech Ltd (NSE: , BSE: 524717) is currently trading at ₹1212.15, with a market capitalization of ₹10.02B. As a leading company in the Health technology sector and Biotechnology industry, monitoring the Titan Biotech Ltd Enterprise Value is essential for fundamental analysis.
Titan Biotech Ltd Enterprise Value Current Value
The current Titan Biotech Ltd Enterprise Value stands at 3.46B.
The Titan Biotech Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Titan Biotech Ltd Enterprise Value Historical Trend
The Titan Biotech Ltd Enterprise Value has shown the following historical trend:
- 2024: 3.46B
- 2023: 4.42B
- 2022: 1.66B
- 2021: 2.19B
- 2020: 1.67B
The decline in Titan Biotech Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Titan Biotech Ltd Enterprise Value Indicates for Investors
The Titan Biotech Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Titan Biotech Ltd.
Titan Biotech Ltd Enterprise Value Analysis Summary
The Titan Biotech Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Titan Biotech Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Titan Biotech Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800